Systematic review and meta‐analysis: Risk of gastric cancer in patients with first‐degree relatives with gastric cancer

Irene Ligato,Ludovica Dottori,Caterina Sbarigia,Emanuele Dilaghi,Bruno Annibale,Edith Lahner,Gianluca Esposito
DOI: https://doi.org/10.1111/apt.17872
IF: 9.524
2024-01-12
Alimentary Pharmacology & Therapeutics
Abstract:First‐degree relatives and gastric cancer risk: A meta‐analysis. Summary Background Gastric cancer ranks fourth in terms of global cancer‐related deaths. Timely identification of high‐risk populations is crucial to reduce mortality. Although a family history of gastric cancer increases risk, European and British guidelines report weak recommendations and low‐quality evidence about the management of these patients. Aim To quantify the association in case–control studies of patients with gastric cancer with first‐degree relatives with gastric cancer compared to those who do not. Methods We conducted a systematic review and meta‐analysis of case–control studies up to November 2023. Data extraction was performed independently by two reviewers. The heterogeneity of effects across studies was quantified by I2. We calculated odds ratios (OR) with 95% confidence intervals (CI) using random effects models. Results We included 30 studies in the systematic review. In all studies, a first‐degree family history of gastric cancer represented a risk factor for gastric cancer. We included 21 studies on the risk of gastric cancer. There was a significantly increased association between gastric cancer and having first‐degree relative(s) with gastric cancer, but with significant heterogeneity among studies (OR = 2.92; 95% CI 2.402–3.552; p
pharmacology & pharmacy,gastroenterology & hepatology
What problem does this paper attempt to address?